These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3962198)

  • 1. [Use of the Fenwal CS-3000 automatic blood cell separator for cytopheresis (review)].
    Fiala J
    Vnitr Lek; 1986 Feb; 32(2):173-9. PubMed ID: 3962198
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preparation of leukocyte and thrombocyte concentrates using the Haemonetics model 30 blood cell separator].
    Fehérvízyová E; Hrubisko M; Danihelová E; Sviteková K
    Vnitr Lek; 1986 Aug; 32(8):784-9. PubMed ID: 3765416
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of the centrifugation speed on the sedimentation behavior of thrombocytes in the CS-3000 Cell Separator (Fenwal)].
    Brauer H; Aulmann HM; Stangel W
    Beitr Infusionther Klin Ernahr; 1987; 18():219-22. PubMed ID: 3439977
    [No Abstract]   [Full Text] [Related]  

  • 4. [Methods of plasmapheresis using blood fractionation devices].
    Kalinin NN
    Sov Med; 1989; (8):40-5. PubMed ID: 2683140
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombocyte aggregate formation during thrombocyte concentrate preparation with the CS-3000 Cell Separator (Fenwal) and its effects on the analysis of the concentrate with the Coulter Counter S Plus IV].
    Wassmann A; Aulmann HM; Stangel W; Meinicke K
    Beitr Infusionther Klin Ernahr; 1987; 18():216-8. PubMed ID: 3439976
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thrombopheresis with the CS-3000 cell separator. Changes in primary hemostasis in the donor and in concentrates in 8-day storage].
    Budde U
    Beitr Infusionther Klin Ernahr; 1986; 15():75-81. PubMed ID: 3092802
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombocytapheresis with the new PLT-30 collection chamber in the CS 3000 Plus cell separator].
    Moog R; Müller N
    Beitr Infusionsther Transfusionsmed; 1994; 32():323-4. PubMed ID: 9480118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viability of 5-day apheresis platelets in a citrate-plasticized bag using a new cell separator.
    Simon TL; Moore RC; Sierra ER; Ferdinando B
    Prog Clin Biol Res; 1990; 337():11-3. PubMed ID: 2352969
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic value of the cell separator. Review and case reports].
    Rossi PL
    Minerva Med; 1979 Apr; 70(18):1289-98. PubMed ID: 450268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombocyte function in vitro using the Fenwal CS-3000 and Haemonetics V50 cell separators].
    Kretschmer V; Ulrich W; Grass H; Heinrich D
    Beitr Infusionther Klin Ernahr; 1986; 15():82-92. PubMed ID: 3753416
    [No Abstract]   [Full Text] [Related]  

  • 11. Donor hemapheresis in France at the start of 1992.
    Coffe C; Norol F
    Transfus Sci; 1993 Apr; 14(2):163-4. PubMed ID: 10150147
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of plateletpheresis on complete blood count values using three different cell separator systems in healthy donors.
    Beyan C; Cetin T; Kaptan K; Nevruz O
    Transfus Apher Sci; 2003 Aug; 29(1):45-7. PubMed ID: 12877892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of the isoradial chamber in the preparation of thrombocyte concentrates using the Travenol CS-3000 separator].
    Bláha M; Jebavý L; Malý J; Siroký O
    Cas Lek Cesk; 1989 Oct; 128(42):1336-7. PubMed ID: 2598246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The safety of apparative cytapheresis].
    Böhm R; Borberg H
    Infusionsther Klin Ernahr; 1987 Sep; 14 Suppl 4():18-27. PubMed ID: 3679527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Storage of haemonetics V50 derived platelets for five days.
    Rock G; Senack E; Tittley P
    Prog Clin Biol Res; 1990; 337():1-5. PubMed ID: 2352966
    [No Abstract]   [Full Text] [Related]  

  • 16. [Initial results with the new cell separator AS 104].
    Kretschmer V; See A; Söhngen D; Bachem M; Kadar JG; Borberg H; Pelzer H; Zöfel P
    Beitr Infusionsther; 1988; 21():113-7. PubMed ID: 2462955
    [No Abstract]   [Full Text] [Related]  

  • 17. Plateletapheresis using single vein access: a comparison of Haemonetics V-50 and Fenwal CS-3000 blood cell separators.
    Vados W; Thompson H; Scott E
    Vox Sang; 1987; 52(3):195-9. PubMed ID: 3604178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technical aspects of buffy coat removal from whole blood and those of platelet production from single buffy coat units.
    Rácz Z; Baróti C
    Biomed Tech (Berl); 1993 Nov; 38(11):266-9. PubMed ID: 8123765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic cytapheresis using the Fenwal CS-3000 blood cell separator.
    Steeper TA; Smith JA; McCullough J
    Vox Sang; 1985; 48(4):193-200. PubMed ID: 3984305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Particle formation in thrombocytapheresis with the cell separator V 50.1].
    Misterek J; Strübel G; Neppert J; Rust H; Mueller-Eckhardt C
    Beitr Infusionsther; 1988; 21():118-21. PubMed ID: 2462956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.